News

Latest news


Warning: Undefined array key "post_id" in /home/clients/b998ca2f1ff8a8c0341cc265bfd02f3c/sites/artiria-medical.com/wp-content/themes/tm21-artiria/template-parts/cell-news.php on line 2
27.02.2024
– Press release

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance.

Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the US following promising first in-human results and FDA clearance.


Warning: Undefined array key "post_id" in /home/clients/b998ca2f1ff8a8c0341cc265bfd02f3c/sites/artiria-medical.com/wp-content/themes/tm21-artiria/template-parts/cell-news.php on line 2
26.05.2023
– Press release

Artiria receives FDA 510(k) clearance for Disruptive Deflectable Guidewire

Artiria Medical, a Swiss neurovascular MedTech company, announces that its real-time deflectable guidewire has been granted the 510(k) clearance by the U.S. Food and Drug Administration (FDA).


Warning: Undefined array key "post_id" in /home/clients/b998ca2f1ff8a8c0341cc265bfd02f3c/sites/artiria-medical.com/wp-content/themes/tm21-artiria/template-parts/cell-news.php on line 2
30.04.2022
– Press release

Artiria raised CHF 3.8 M to improve stroke treatments

Artiria Medical raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective EIC accelerator program and a CHF 1.1 M bridge financing.